|
Home /
Kos Pharmaceuticals
Kos Pharmaceuticals
Kos Pharmaceuticals
Kos Pharmaceuticals was fully acquired by
Abbott around the end of
December 2006. The final step in the aquisition of Kos Pharmaceuticals resulted
after Abbott aquired the remaining 8.6% of the Company's shares, meaning that
as of that date, Kos Pharmaceuticals became a wholly owned subsidiary of
Abbott. Kos Pharmaceutical's is a specialty pharmaceutical company with key
interests is chronic cardiovascular, metabolic and respiratory
diseases.
Abbott
Pharmaceutical |